Sep 2026
KRAS/ERK2-driven stabilization of AARS1 reprograms tumor metabolism and confers Sorafenib resistance in lung adenocarcinoma.
Wen-Xuan Hu, Zhi-Ke Chen, Jian Yang et al.
· Cell Death and Differentiati... · 0 citations